EUVIMEDEUVIMED entdecken
Crossref

Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes

Liwen Feng iD, Yuting Chen, Xiangping Mei, Lei Wang, Wenjing Zhao, Jiannan Yao

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2024.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Liwen Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Amino Acids, Nomograms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma (OS) is undeniably a formidable bone malignancy characterized by a scarcity of effective treatment options. Reprogramming of amino acid (AA) metabolism has been associated with OS development. The present study was designed to identify metabolism-associated genes (MAGs) that are differentially expressed in OS and to construct a MAG-based prognostic risk signature for this disease.

Methods

Expression profiles and clinicopathological data were downloaded from Gene Expression Omnibus (GEO) and UCSC Xena databases. A set of AA MAGs was obtained from the MSigDB database. Differentially expressed genes (DEGs) in GEO dataset were identified using "limma." Prognostic MAGs from UCSC Xena database were determined through univariate Cox regression and used in the prognostic signature development. This signature was validated using another dataset from GEO database. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, single sample gene set enrichment analysis, and GDSC2 analyses were performed to explore the biological functions of the MAGs. A MAG-based nomogram was established to predict 1-, 3-, and 5-year survival. Real-time quantitative polymerase chain reaction, Western blot, and immunohistochemical staining confirmed the expression of MAGs in primary OS and paired adjacent normal tissues.

Results

A total of 790 DEGs and 62 prognostic MAGs were identified. A MAG-based signature was constructed based on four MAGs: PIPOX, PSMC2, SMOX, and PSAT1. The prognostic value of this signature was successfully validated, with areas under the receiver operating characteristic curves for 1-, 3-, and 5-year survival of 0.714, 0.719, and 0.715, respectively. This MAG-based signature was correlated with the infiltration of CD56dim natural killer cells and resistance to several antiangiogenic agents. The nomogram was accurate in predictions, with a C-index of 0.77. The expression of MAGs verified by experiment was consistent with the trends observed in GEO database.

Conclusion

Four AA MAGs were prognostic of survival in OS patients. This MAG-based signature has the potential to offer valuable insights into the development of treatments for OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsAmino AcidsNomogramsHumansPrognosisMaleFemaleBiomarkers, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticDatabases, Genetic

Stichwörter der Autor:innen

GEOUCSC Xenaamino acid metabolismbioinformaticsbone tumorprediction model

Substanzen

Amino AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Liwen Feng

Zitieren

APA

Feng, L., Chen, Y., Mei, X., Wang, L., Zhao, W., & Yao, J. (2024). Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0002

Vancouver

Feng L, Chen Y, Mei X, Wang L, Zhao W, Yao J. Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2024.0002

BibTeX
@article{Feng2024,
  author = {Feng, Liwen and Chen, Yuting and Mei, Xiangping and Wang, Lei and Zhao, Wenjing and Yao, Jiannan},
  title = {Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2024.0002}
}
Kostenlos starten →